Evidence map›Paper›PMID 18482976›Full record

ArticleThe Journal of biological chemistry2008

A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats.

Natalia Beloglazova, Greg Brown, Matthew D Zimmerman, Michael Proudfoot, Kira S Makarova, Marina Kudritska, Samvel Kochinyan, Shuren Wang, Maksymilian Chruszcz, Wladek Minor and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 200 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. CRISPR-Cas Systems: A Functional Perspective and Innovations.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Diversity, Origin and Evolution of the ESCRT Systems.bioRxiv : the preprint server for biology · 2024
    Article
  13. Advances in application of CRISPR-Cas13a system.Frontiers in cellular and infection microbiology · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Discovery in CRISPR-Cas9 system.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  19. Article
  20. Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Natalia BeloglazovaBanting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, Canada.
Greg Brown
Matthew D Zimmerman
Michael Proudfoot
Kira S Makarova
Marina Kudritska
Samvel Kochinyan
Shuren Wang
Maksymilian Chruszcz
Wladek Minor
Eugene V Koonin
Aled M Edwards
Alexei Savchenko
Alexander F Yakunin
Ontario Institute for Cancer Research · CAArgonne National Laboratory · USNational Institutes of Health · US

Funding

The Midwest Center for Structural GenomicsU54GM074942 · NIGMS · UNIVERSITY OF CHICAGO · PI JOACHIMIAK, ANDRZEJ · 2005 to 2009
$51.0M
THE MIDWEST CENTER FOR STRUCTURAL GENOMICSP50GM062414 · NIGMS · UNIVERSITY OF CHICAGO · PI JOACHIMIAK, ANDRZEJ JOACHIMIAK · 2000 to 2004
$33.2M
Finding Protein Sequence Motifs--Methods And ApplicationsZIALM000061 · NLM · NATIONAL LIBRARY OF MEDICINE · PI KOONIN, EUGENE V · 2009 to 2025
$10.6M
Intramural NIH HHSNIGMS NIH HHS GM 074942NIGMS NIH HHS GM 62414
6 · The paper itself

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPRs) together with the associated CAS proteins protect microbial cells from invasion by foreign genetic elements using presently unknown molecular mechanisms. All CRISPR systems contain proteins of the CAS2 family, suggesting that these uncharacterized proteins play a central role in this process. Here we show that the CAS2 proteins represent a novel family of endoribonucleases. Six purified CAS2 proteins from diverse organisms cleaved single-stranded RNAs preferentially within U-rich regions. A representative CAS2 enzyme, SSO1404 from Sulfolobus solfataricus, cleaved the phosphodiester linkage on the 3'-side and generated 5'-phosphate- and 3'-hydroxyl-terminated oligonucleotides. The crystal structure of SSO1404 was solved at 1.6A resolution revealing the first ribonuclease with a ferredoxin-like fold. Mutagenesis of SSO1404 identified six residues (Tyr-9, Asp-10, Arg-17, Arg-19, Arg-31, and Phe-37) that are important for enzymatic activity and suggested that Asp-10 might be the principal catalytic residue. Thus, CAS2 proteins are sequence-specific endoribonucleases, and we propose that their role in the CRISPR-mediated anti-phage defense might involve degradation of phage or cellular mRNAs.

Indexed as

Amino Acid SequenceBase SequenceConserved SequenceCrystallography, X-RayEndoribonucleasesGene Expression Regulation, EnzymologicModels, MolecularMolecular Sequence DataMultigene FamilyMutationNucleic Acid ConformationProtein Structure, QuaternaryProtein Structure, TertiaryRNASequence AlignmentSubstrate SpecificityEndoribonucleasesRNA

Identifiers

PMID18482976
PMCPMC2459268
OpenAlexW2057964816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.